HemOnc Melanoma Tumor Board 2025-26A – CME - 1/21/2026

Add to Calendar HemOnc Melanoma Tumor Board 2025-26A – CME - 1/21/2026 1/21/2026 7:30:00 AM 1/21/2026 8:30:00 AM America/Chicago For More Details: https://vumc.cloud-cme.com/course/courseoverview?EID=99361 Description: The Melanoma Tumor Board is offered every Wednesday from 7:30 to 8:30 am virtually. Each session provides opportunities for attendings, fellows, and residents to examine recent cases and discuss application of new knowledge and/or discuss opportunities for improvement. After participating in this CME activity, participants should be able to the proper diagnosis, evaluation and management of patients wi... Online false MM/DD/YYYY


Wednesday, January 21, 2026, 7:30 AM - 8:30 AM, Online


Specialties - Dermatology, Medicine, Otolaryngology, Pathology, Microbiology and Immunology, Radiation Oncology, Radiology and Radiological Sciences, Surgery


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)


The Melanoma Tumor Board is offered every Wednesday from 7:30 to 8:30 am virtually. Each session provides opportunities for attendings, fellows, and residents to examine recent cases and discuss application of new knowledge and/or discuss opportunities for improvement. After participating in this CME activity, participants should be able to the proper diagnosis, evaluation and management of patients with melanoma, the role of surgery and radiation therapy in localized melanoma, and the role of medical oncology and emerging therapies in melanoma.

Objective(s): 1 Describe and discuss he proper diagnosis, evaluation and management of patients with melanoma 2 Describe and discuss the role of surgery and radiation therapy in localized melanoma 3 Describe and discuss the role of medical oncology and emerging therapies in melanoma
Location: Online
Specialties: Dermatology, Otolaryngology, Medicine, Pathology, Microbiology and Immunology, Radiation Oncology, Radiology and Radiological Sciences, Surgery

Faculty Disclosures:
Douglas B Johnson, MD (Advisor-BMS|Advisor-Daiichi Sankyo (Relationship has ended)|Advisor-Merck|Advisor-Pfizer|Advisor-AstraZeneca (Relationship has ended)|Advisor-Jackson Labs - 06/12/2025)



Objectives
After participating in this educational activity, you should be able to:

  1. Describe and discuss he proper diagnosis, evaluation and management of patients with melanoma
  2. Describe and discuss the role of surgery and radiation therapy in localized melanoma
  3. Describe and discuss the role of medical oncology and emerging therapies in melanoma


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this live activity for a maximum 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.